ID   St-4/CPT
AC   CVCL_H266
SY   St-4 / CPT
DR   CGH-DB; 9108-4
DR   Wikidata; Q54955735
RX   PubMed=2170010;
RX   PubMed=14973057;
CC   Population: Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_27656; Camptothecin (CPT).
DI   NCIt; C4911; Gastric carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_H265 ! St-4
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 10
//
RX   PubMed=2170010;
RA   Sugimoto Y., Tsukahara S., Oh-hara T., Isoe T., Tsuruo T.;
RT   "Decreased expression of DNA topoisomerase I in camptothecin-resistant
RT   tumor cell lines as determined by a monoclonal antibody.";
RL   Cancer Res. 50:6925-6930(1990).
//
RX   PubMed=14973057; DOI=10.1158/0008-5472.CAN-3263-2;
RA   Yasui K., Mihara S., Zhao C., Okamoto H., Saito-Ohara F., Tomida A.,
RA   Funato T., Yokomizo A., Naito S., Imoto I., Tsuruo T., Inazawa J.;
RT   "Alteration in copy numbers of genes as a mechanism for acquired drug
RT   resistance.";
RL   Cancer Res. 64:1403-1410(2004).
//